Clinical comorbidity phenotypes in COPD and their biomarker signatures
Line Egerod, Diana J. Leeming, Morten A. Karsdal, Julie C. Yates, Jannie M.B. Sand, Cecilie L. Bager · 2026
Read Clinical comorbidity phenotypes in COPD and their biomarker signatures by Line Egerod, Diana J. Leeming, Morten A. Karsdal, Julie C. Yates, Jannie M.B. Sand, Cecilie L. Bager (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13531309.txt.
Description
Line Egerod and co-authors, in a paper from 2026, sort people with chronic obstructive pulmonary disease into groups based on other health problems they also have. The short report says blood markers of swelling, clotting, and scar forming activity differ across those groups. Those gaps point to real body based patterns, not just chance. They may mark types that show early, hidden disease steps. The work hints that care could one day be matched to a group and its marker pattern.
Catalog record
| CREATOR | Line Egerod, Diana J. Leeming, Morten A. Karsdal, Julie C. Yates, Jannie M.B. Sand, Cecilie L. Bager |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 11 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |